Tag Archives: open innovation

There’s a lot of talk today about “open innovation” in business and research forums—but what exactly does it mean? How does open innovation as a concept apply to the pharma sector? Does it signal a change in the way pharma companies approach research and innovation? Roy F. Waldron reports. There are a number of highly innovative [...]